BioCentury
ARTICLE | Company News

Management tracks

July 21, 2017 12:27 AM UTC

Enzyme therapy company Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) said President and CEO David Lowe resigned. Director and former interim CMO Anthony Quinn will be interim CEO while the company seeks Lowe's successor.

Neurology and cardiovascular company Trevena Inc. (NASDAQ:TRVN) said CMO David Soergel will resign in late August. The company is searching for a replacement...